Even if you’ve had atopic dermatitis most of your life, this form of eczema can change as you get older. Find out what to be ...

Northwell Health reports on how to support a loved one diagnosed with breast cancer, highlighting what to say and what to ...

AbbVie (NYSE: ABBV) today announced new research across its diverse dermatology portfolio to be presented at the 2026 European Academy of Dermatology and Venereology (EADV) Congress – October 3 in ...

It’s on every acne-fighting guide. I love this gel so much that I slather it all over my face for super smooth, clear skin.

VI Peel CEO Marya Khalil-Otto on the chemical peel her late father created for her acne, and how she built it into a brand ...

If you are an FtM or FtX individual considering hormone therapy, you are likely already aware of some of the benefits and ...

Dark spots are one of most common signs of skin aging. In general, an anti-aging serum that contains exfoliating ingredients, ...

SAN ANTONIO — Acne is a frustrating condition that most people experience as they grow into adulthood. In this edition of Healthy SA, experts say having acne as an adult may be more common than you ...

AIIMS Delhi is studying PMOS among nearly 4,000 schoolgirls. Check key symptoms, diagnosis criteria and what parents should ...

AIIMS Delhi conducts a comprehensive study revealing the rising prevalence of polyendocrine metabolic ovarian syndrome (PMOS) ...

RINVOQ is now approved in the European Union for the treatment of active polyarticular juvenile idiopathic arthritis (pJIA) in patients two years of age ...

NORTH CHICAGO, Ill., Sept. 22, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the European Commission (EC) has approved RINVOQ® (upadacitinib; 15 mg tablet and weight-based 1 mg/mL oral ...